Barlattani T

Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L' Aquila, Via Vetoio, (Coppito 2), L' Aquila, 67100, Italy.

1 preprint · 1 paper

PreprintKetamine

Intranasal Esketamine for Treatment-Resistant Depression: A Practical Clinical Guide to Patient Selection, Dosing, Combination Strategies and Adverse-Event Management

De Berardis D, Barlattani T, Carano A +10

Europe PMC2026
ArticleKetamine

Dimensional effect profiles in treatment-resistant depression: A naturalistic, prospective head-to-head comparison of arTMS, esketamine nasal spray, and oral brexpiprazole.

d'Andrea G, Cavallotto C, Susini O +10

Europe PMC2026